Astra offers physician-prescribed compounded GLP-1 therapies alongside brand-name Wegovy, Ozempic, and Zepbound. Each program is evaluated and titrated by US-licensed physicians.
Astra's weight-loss category includes compounded GLP-1 programs (semaglutide from $96/mo, tirzepatide from $125/mo) alongside brand-name Wegovy, Ozempic, and Zepbound.
Each program is evaluated and titrated by US-licensed physicians. All plans include provider messaging, supplies, and coordinated pharmacy shipping.